Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Oncogene|March 16, 2002
Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiationArshad Amanullah, Dan A Liebermann, Barbara HoffmanOncogene|May 29, 2002
The proto-oncogene c-myc in hematopoietic development and leukemogenesisBarbara Hoffman, Arshad Amanullah, Marianna Shafarenko, et al.Blood|February 26, 2004
Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiationMarianna Shafarenko, Arshad Amanullah, Bernard Gregory, et al.Blood|February 21, 2004
Mechanisms associated with IL-6-induced up-regulation of Jak3 and its role in monocytic differentiationJames K Mangan, Sushil G Rane, Anthony D Kang, et al.Vaccine|October 9, 2017
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-inferiority trialOpokua Ofori-Anyinam, Geert Leroux-Roels, Mamadou Drame, et al.Blood|September 28, 2002
Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cellsSushil G Rane, James K Mangan, Arshad Amanullah, et al.The Pediatric Infectious Disease Journal|July 16, 2019
Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza VaccineJasur Danier, Luis Rivera, Carine Claeys, et al.The Pediatric Infectious Disease Journal|November 15, 2019
Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical TrialGhassan Dbaibo, Arshad Amanullah, Carine Claeys, et al.Pageof 1